Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial Lori M. Laffel Summary of Research Open access 05 April 2024 Pages: 893 - 896
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel Adam G. TabakPeter KemplerBoris Mankovsky Review Open access 12 March 2024 Pages: 897 - 915
The Implication of Diabetes-Specialized Nurses in Aiming for the Better Treatment and Management of Patients with Diabetes Mellitus: A Brief Narrative Review Yefang ZhuHongmei ZhangHong Lei Review Open access 12 March 2024 Pages: 917 - 927
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design Kristin CastorinoBeatrice OsumiliCarolina Piras de Oliveira Review Open access 18 March 2024 Pages: 929 - 1045
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis Esteban J. GimenoMette BøgelundDomingo Orozco-Beltran Review Open access 23 March 2024 Pages: 1047 - 1067
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes Robert M. GutgesellRubén NogueirasTimo D. Müller Review Open access 04 April 2024 Pages: 1069 - 1084
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review Janet B. McGillIrl B. HirschJames R. Gavin III Review Open access 04 April 2024 Pages: 1085 - 1098
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review Samuel SeiduVicki AlabrabaJohn P. H. Wilding Review Open access 05 April 2024 Pages: 1099 - 1124
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups Yan BiSong LuLinong Ji Original Research Open access 18 March 2024 Pages: 1125 - 1137
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study Sakiko TeruiMari IgariJun Shirakawa Original Research Open access 18 March 2024 Pages: 1139 - 1153
Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes Anu GuptaAlpesh GoyalYashdeep Gupta Original Research Open access 23 March 2024 Pages: 1155 - 1168
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity Klara R. KleinTrine J. Abrahamsenon behalf of the N3C Consortium Original Research Open access 27 March 2024 Pages: 1169 - 1186
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study Akiko TakahashiManabu IshiiMakoto Kunisaki Original Research Open access 30 March 2024 Pages: 1187 - 1199
An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D) Kevin M. PantaloneBruce RogenBartolome Burguera Original Research Open access 04 April 2024 Pages: 1201 - 1214
Aberrant Brain Triple-Network Effective Connectivity Patterns in Type 2 Diabetes Mellitus Yujie ZhangXiao YinXindao Yin Original Research Open access 05 April 2024 Pages: 1215 - 1229
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial Xiaxuan ZhuLi XiaRui Wei Study Protocol Open access 18 March 2024 Pages: 1231 - 1244
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study) Tamiko TamanahaHisashi MakinoKiminori Hosoda Study Protocol Open access 04 April 2024 Pages: 1245 - 1254